Results 251 to 260 of about 186,093 (261)

Sodium–Glucose Cotransporter–2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes

Annual Review of Medicine, 2019
Caroline K Kramer
exaly  

Twenty-Four-Hour Blood Pressure–Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension

Circulation, 2019
Kazuomi Kario, Takeshi Fujiwara, Hiroshi Kanegae   +2 more
exaly  

Bile Diversion in Roux-en-Y Gastric Bypass Modulates Sodium-Dependent Glucose Intestinal Uptake

Cell Metabolism, 2016
Marie Pigeyre, Caroline Bonner, André Klein   +2 more
exaly  

Sodium Intake Regulates Glucose Homeostasis through the PPARδ/Adiponectin-Mediated SGLT2 Pathway

Cell Metabolism, 2016
Peng Gao, Aimin Xu, Yu Huang
exaly  

Biology of Human Sodium Glucose Transporters

Physiological Reviews, 2011
Ernest M Wright
exaly  

The role of the kidneys in glucose homeostasis in type 2 diabetes: Clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors

Metabolism: Clinical and Experimental, 2014
John P H Wilding
exaly  

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition

Diabetes Care, 2015
Anne Peters Harmel, Irl B Hirsch
exaly  

Use of Sodium Glucose Cotransporter 2 Inhibitors in the Hands of Cardiologists

Circulation, 2016
Jacob A Udell, David Z I Cherney
exaly  

Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes

Endocrine Reviews, 2011
Luke Norton, Ralph A Defronzo
exaly  

A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)

European Journal of Heart Failure, 2019
John J V Mcmurray, David L Demets, Lars Køber   +2 more
exaly